SCHEMBL24256473

SCHEMBL24256473

c1ccc(-c2ccc(N(c3ccc4ccccc4c3)c3ccc(-c4nc(-c5ccccc5)nc(-c5cccc6oc7ccccc7c56)n4)c4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.33
ALDH1A1 P00352 8/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
KMT2A Q03164 4/20 0.32
HSD17B10 Q99714 3/20 0.32
TSHR P16473 3/20 0.32
LMNA P02545 2/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
ALOX5 P09917 1/20 0.31
CYP1A2 P05177 3/20 0.31
MEN1 O00255 3/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
TP53 P04637 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CYP3A4 P08684 1/20 0.31
HPGD P15428 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24256089 0.96 MAPT (0.35) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL26313051 0.93 MAPT (0.37) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL24256093 0.92 MAPT (0.36) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL26313050 0.92 ALOX5 (0.36) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL24256471 0.90 BRDT (0.31) MAPT
SCHEMBL24256430 0.90 ALDH1A1 (0.37) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25975859 0.90 MAPT (0.32) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL24255869 0.89 MAPT (0.40) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL26313044 0.88 ALDH1A1 (0.38) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL24255858 0.87 ALDH1A1 (0.35) MAPTALDH1A1KDM4EPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
WO-2022035224-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE 엘티소재주식회사 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 MAPT 376/4885ALDH1A1 412/4885KDM4E 2416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.